Status:
UNKNOWN
Lee Silverman Voice Treatment Versus Standard Speech Therapy Versus Control in Hypophonia Rehabilitation in MS
Lead Sponsor:
Fondazione Don Carlo Gnocchi Onlus
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The aim of the study is to identify the most effective method of intervention to reduce hypophonia in PwMS (Patient With Multiple Sclerosis), as a way to optimize the speech-therapy treatment based on...
Detailed Description
The descriptive studies showed that voice problems, in particular hypophonia, are present in 45% to 91% of patients with multiple sclerosis and may constitute a limitation in social life participation...
Eligibility Criteria
Inclusion
- Diagnosis of Multiple Sclerosis according with McDonald's criteria;
- absence of relaps in the last month;
- Mini Mental State Examination (MMSE) \> 21 score for a better understanding and adherence to the execution of the proposed exercises;
- hypophonia (conversation \< 60 dB SPL- distance was kept equal at about 15 cm);
- ability to understand the aims of the study and acceptance to sign an informed consent;
- acceptance of the intensity of the treatment;
- ability to understand the Italian language.
Exclusion
- Presence of other neurological disorders;
- visual/hearing impairments hindering the rehabilitation program;
- clinical history of laryngeal cancer, chemotherapy, radiotherapy, head and neck trauma or endotracheal intubation;
- relapse or sudden changes in their MS symptoms within the previous 3 months.
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04034277
Start Date
January 15 2018
End Date
March 30 2020
Last Update
July 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Don Gnocchi Irccs
Milan, Italy